The World Health Organization has rejected Medicago’s COVID\u002D19 vaccine, restricting the federal government’s ability to donate those doses to countries in need.
Health Canada authorized Medicago’s two-dose Covifenz vaccine in February for adults 18 to 64.
Medicago says WHO did “not accept” its application because it has a strict policy not to engage with companies that promote tobacco, and Philip Morris owns about one-fifth of the company. WHO says it is now exploring different policy options for health products linked to the tobacco industry.tap here to see other videos from our teamThe federal government signed an agreement with Medicago in 2020 to buy 20 million doses once the vaccine was approved by Health Canada, with the option to purchase 56 million more.
The government’s ability to donate those doses to countries in need could be seriously impeded without WHO emergency approval.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna says its low-dose COVID shots work for kids under 6Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers
Read more »
Can drugs reduce the risk of long COVID? What scientists know so farResearchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms.
Read more »
NPR Cookie Consent and Choices
Read more »
Moderna says its low-dose COVID-19 vaccine works for kids younger than 6Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters younger than 6.
Read more »
Moderna says its low-dose COVID shots work for kids under 6Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday — a development that could pave the way for the littlest kids to be vaccinated by …
Read more »
We're 1 Step Closer to a COVID Vaccine For Children Under 6Moderna is prepping to ask the FDA for approval of its COVID-19 vaccine for children between 6 months and 6 years old in light of new research data.
Read more »